Skip to main content
Premium Trial:

Request an Annual Quote

Microba, Psomagen Partner to Launch Microbiome Test in US

NEW YORK — Australian biotech firm Microba said today that it has partnered with Macrogen subsidiary Psomagen to introduce a microbiome analysis test in the US.

Microba recently launched a direct-to-consumer service in Australia called Insight, which uses shotgun metagenomics to analyze customers' gut microbiomes and generate a personalized report. Under the terms of the deal, Psomagen will introduce a microbiome test based on Microba's technologies in the US before the end of the year.

Additional terms were not disclosed.

The partnership represents the latest step in an ongoing alliance between Microba and Rockville, Maryland-based Psomagen, a recently renamed subsidiary of South Korea's Macrogen. In March, Microba began working with Macrogen to develop microbiome research services for international markets. A few months later, Macrogen made a $2.8 million investment in Microba.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.